Hans-Christoph Schneider, Research Scientist in the Department of Computational Biology and Bioinformatics, Sanofi Deutschland
July 2000 – present: Aventis Pharma/Sanofi-Aventis Deutschland GmbH, Frankfurt (Germany).
Research scientist in Bioinformatics & Systems Biology.
Current work: Mathematical modeling of processes in the pancreatic beta-cell and in the glucose insulin system.
July 1999 – June 2000: Aventis Pharma (formerly Rhône-Poulenc Rorer) Ltd., Dagenham (United Kingdom).
Research scientist in the Bioinformatics Group of the Molecular Biology Department.
Dec. 1996 - June1999: Rhône-Poulenc Rorer Ltd., Dagenham (United Kingdom).
Research scientist in the Molecular Biology Department in the therapeutic area for asthma and inflammation.
Sept. 1992 – Nov. 1996 PhD thesis
under the supervision of Prof. Dr. Dr. Walter Neupert at the
Institute for Physiological Chemistry, University of Munich (Germany)
Title: “The role of Tim44 in mitochondrial protein import“
Nov. 1991 – June 1992 Diploma thesis
under the supervision of Nobel Laureate Prof. Dr. Robert Huber at the Max-Planck-Institute for Biochemistry, Martinsried (Germany)
Title: “Crystallographic investigations on a thermostable alpha amylase from Bacillus licheniformis“
Sept. 1989 – June 1992 Diploma in Biochemistry
University of Hannover (Germany)
Sept. 1988 – Aug. 1989 Master of Science in Biochemistry
University of California, Riverside (USA)
Oct. 1985 – Sept. 1988 Vordiplom in Biochemistry
Eberhard-Karls-University, Tübingen (Germany)